Pfizer CEO Albert Bourla says mRNA technology was ‘counterintuitive’.
Pfizer CEO Albert Bourla says mRNA technology was ‘counterintuitive’.

Pfizer CEO Albert Bourla says mRNA technology was ‘counterintuitive’ being that Pfizer had less than 2 years of experience with it and no products on the market using it.